Industry Research Reports

Home > Reports > Chemical & Material > Puerarin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Puerarin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-13

Pages: 94 Pages

Report ld: 3482913

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Puerarin Market Size(US$)

CAGR 2025-2031

6.7%

Market Size,2031

USD 176

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 119 million

Market Forecast in 2031(Value)

US$ 176 million

CAGR

6.7%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Puerarin was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 176 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.

Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.

The industry trend for Puerarin reflects the increasing interest in natural bioactive compounds with potential therapeutic effects. With a growing demand for plant-based and holistic approaches to healthcare and wellness, there is a rising focus on botanical ingredients like Puerarin. The pharmaceutical industry is exploring the use of Puerarin in drug development, particularly for cardiovascular applications and neuroprotective effects. Additionally, the nutraceutical and dietary supplement industry is incorporating Puerarin into formulations targeting specific health concerns, including cardiovascular health, cognitive function, and menopausal symptoms. This industry trend aligns with the broader movement towards natural and plant-based alternatives in healthcare and wellness.

This report aims to provide a comprehensive presentation of the global market for Puerarin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Puerarin by region & country, by Type, and by Application.

The Puerarin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Puerarin.

MARKET SEGMENTATION

By Company

Ankang Health Element
Jiangsu Tiansheng
Xi'an Plamed
Xi'an Sobeo
Ankang Health Element
Shanxi Zhongyi Herb

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

98% Content
Other Content

Segment by Application

Pharmaceutical
Research

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Puerarin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Puerarin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Puerarin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Puerarin Product Introduction

1.2 Global Puerarin Market Size Forecast

1.2.1 Global Puerarin Sales Value (2020-2031)

1.2.2 Global Puerarin Sales Volume (2020-2031)

1.2.3 Global Puerarin Sales Price (2020-2031)

1.3 Puerarin Market Trends & Drivers

1.3.1 Puerarin Industry Trends

1.3.2 Puerarin Market Drivers & Opportunity

1.3.3 Puerarin Market Challenges

1.3.4 Puerarin Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Puerarin Players Revenue Ranking (2024)

2.2 Global Puerarin Revenue by Company (2020-2025)

2.3 Global Puerarin Players Sales Volume Ranking (2024)

2.4 Global Puerarin Sales Volume by Company Players (2020-2025)

2.5 Global Puerarin Average Price by Company (2020-2025)

2.6 Key Manufacturers Puerarin Manufacturing Base and Headquarters

2.7 Key Manufacturers Puerarin Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Puerarin

2.9 Puerarin Market Competitive Analysis

2.9.1 Puerarin Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Puerarin Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Puerarin as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 98% Content

3.1.2 Other Content

3.2 Global Puerarin Sales Value by Type

3.2.1 Global Puerarin Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Puerarin Sales Value, by Type (2020-2031)

3.2.3 Global Puerarin Sales Value, by Type (%) (2020-2031)

3.3 Global Puerarin Sales Volume by Type

3.3.1 Global Puerarin Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Puerarin Sales Volume, by Type (2020-2031)

3.3.3 Global Puerarin Sales Volume, by Type (%) (2020-2031)

3.4 Global Puerarin Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceutical

4.1.2 Research

4.2 Global Puerarin Sales Value by Application

4.2.1 Global Puerarin Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Puerarin Sales Value, by Application (2020-2031)

4.2.3 Global Puerarin Sales Value, by Application (%) (2020-2031)

4.3 Global Puerarin Sales Volume by Application

4.3.1 Global Puerarin Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Puerarin Sales Volume, by Application (2020-2031)

4.3.3 Global Puerarin Sales Volume, by Application (%) (2020-2031)

4.4 Global Puerarin Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Puerarin Sales Value by Region

5.1.1 Global Puerarin Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Puerarin Sales Value by Region (2020-2025)

5.1.3 Global Puerarin Sales Value by Region (2026-2031)

5.1.4 Global Puerarin Sales Value by Region (%), (2020-2031)

5.2 Global Puerarin Sales Volume by Region

5.2.1 Global Puerarin Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Puerarin Sales Volume by Region (2020-2025)

5.2.3 Global Puerarin Sales Volume by Region (2026-2031)

5.2.4 Global Puerarin Sales Volume by Region (%), (2020-2031)

5.3 Global Puerarin Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Puerarin Sales Value, 2020-2031

5.4.2 North America Puerarin Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Puerarin Sales Value, 2020-2031

5.5.2 Europe Puerarin Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Puerarin Sales Value, 2020-2031

5.6.2 Asia Pacific Puerarin Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Puerarin Sales Value, 2020-2031

5.7.2 South America Puerarin Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Puerarin Sales Value, 2020-2031

5.8.2 Middle East & Africa Puerarin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Puerarin Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Puerarin Sales Value

6.2.1 Key Countries/Regions Puerarin Sales Value, 2020-2031

6.2.2 Key Countries/Regions Puerarin Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Puerarin Sales Value, 2020-2031

6.3.2 United States Puerarin Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Puerarin Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Puerarin Sales Value, 2020-2031

6.4.2 Europe Puerarin Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Puerarin Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Puerarin Sales Value, 2020-2031

6.5.2 China Puerarin Sales Value by Type (%), 2024 VS 2031

6.5.3 China Puerarin Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Puerarin Sales Value, 2020-2031

6.6.2 Japan Puerarin Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Puerarin Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Puerarin Sales Value, 2020-2031

6.7.2 South Korea Puerarin Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Puerarin Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Puerarin Sales Value, 2020-2031

6.8.2 Southeast Asia Puerarin Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Puerarin Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Puerarin Sales Value, 2020-2031

6.9.2 India Puerarin Sales Value by Type (%), 2024 VS 2031

6.9.3 India Puerarin Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Ankang Health Element

7.1.1 Ankang Health Element Company Information

7.1.2 Ankang Health Element Introduction and Business Overview

7.1.3 Ankang Health Element Puerarin Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Ankang Health Element Puerarin Product Offerings

7.1.5 Ankang Health Element Recent Development

7.2 Jiangsu Tiansheng

7.2.1 Jiangsu Tiansheng Company Information

7.2.2 Jiangsu Tiansheng Introduction and Business Overview

7.2.3 Jiangsu Tiansheng Puerarin Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Jiangsu Tiansheng Puerarin Product Offerings

7.2.5 Jiangsu Tiansheng Recent Development

7.3 Xi'an Plamed

7.3.1 Xi'an Plamed Company Information

7.3.2 Xi'an Plamed Introduction and Business Overview

7.3.3 Xi'an Plamed Puerarin Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Xi'an Plamed Puerarin Product Offerings

7.3.5 Xi'an Plamed Recent Development

7.4 Xi'an Sobeo

7.4.1 Xi'an Sobeo Company Information

7.4.2 Xi'an Sobeo Introduction and Business Overview

7.4.3 Xi'an Sobeo Puerarin Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Xi'an Sobeo Puerarin Product Offerings

7.4.5 Xi'an Sobeo Recent Development

7.5 Ankang Health Element

7.5.1 Ankang Health Element Company Information

7.5.2 Ankang Health Element Introduction and Business Overview

7.5.3 Ankang Health Element Puerarin Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Ankang Health Element Puerarin Product Offerings

7.5.5 Ankang Health Element Recent Development

7.6 Shanxi Zhongyi Herb

7.6.1 Shanxi Zhongyi Herb Company Information

7.6.2 Shanxi Zhongyi Herb Introduction and Business Overview

7.6.3 Shanxi Zhongyi Herb Puerarin Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Shanxi Zhongyi Herb Puerarin Product Offerings

7.6.5 Shanxi Zhongyi Herb Recent Development

8 Industry Chain Analysis

8.1 Puerarin Industrial Chain

8.2 Puerarin Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Puerarin Sales Model

8.5.2 Sales Channel

8.5.3 Puerarin Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Puerarin Market Trends

Table 2. Puerarin Market Drivers & Opportunity

Table 3. Puerarin Market Challenges

Table 4. Puerarin Market Restraints

Table 5. Global Puerarin Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Puerarin Revenue Market Share by Company (2020-2025)

Table 7. Global Puerarin Sales Volume by Company (2020-2025) & (Tons)

Table 8. Global Puerarin Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Puerarin Price by Company (2020-2025) & (US$/Ton)

Table 10. Key Manufacturers Puerarin Manufacturing Base and Headquarters

Table 11. Key Manufacturers Puerarin Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Puerarin

Table 13. Global Puerarin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Puerarin as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Puerarin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Puerarin Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Puerarin Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Puerarin Sales Market Share in Value by Type (2020-2025)

Table 20. Global Puerarin Sales Market Share in Value by Type (2026-2031)

Table 21. Global Puerarin Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Puerarin Sales Volume by Type (2020-2025) & (Tons)

Table 23. Global Puerarin Sales Volume by Type (2026-2031) & (Tons)

Table 24. Global Puerarin Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Puerarin Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Puerarin Price by Type (2020-2025) & (US$/Ton)

Table 27. Global Puerarin Price by Type (2026-2031) & (US$/Ton)

Table 28. Global Puerarin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Puerarin Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Puerarin Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Puerarin Sales Market Share in Value by Application (2020-2025)

Table 32. Global Puerarin Sales Market Share in Value by Application (2026-2031)

Table 33. Global Puerarin Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)

Table 34. Global Puerarin Sales Volume by Application (2020-2025) & (Tons)

Table 35. Global Puerarin Sales Volume by Application (2026-2031) & (Tons)

Table 36. Global Puerarin Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Puerarin Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Puerarin Price by Application (2020-2025) & (US$/Ton)

Table 39. Global Puerarin Price by Application (2026-2031) & (US$/Ton)

Table 40. Global Puerarin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Puerarin Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Puerarin Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Puerarin Sales Value by Region (2020-2025) & (%)

Table 44. Global Puerarin Sales Value by Region (2026-2031) & (%)

Table 45. Global Puerarin Sales Volume by Region (Tons): 2020 VS 2024 VS 2031

Table 46. Global Puerarin Sales Volume by Region (2020-2025) & (Tons)

Table 47. Global Puerarin Sales Volume by Region (2026-2031) & (Tons)

Table 48. Global Puerarin Sales Volume by Region (2020-2025) & (%)

Table 49. Global Puerarin Sales Volume by Region (2026-2031) & (%)

Table 50. Global Puerarin Average Price by Region (2020-2025) & (US$/Ton)

Table 51. Global Puerarin Average Price by Region (2026-2031) & (US$/Ton)

Table 52. Key Countries/Regions Puerarin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Puerarin Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Puerarin Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Puerarin Sales Volume, (2020-2025) & (Tons)

Table 56. Key Countries/Regions Puerarin Sales Volume, (2026-2031) & (Tons)

Table 57. Ankang Health Element Company Information

Table 58. Ankang Health Element Introduction and Business Overview

Table 59. Ankang Health Element Puerarin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 60. Ankang Health Element Puerarin Product Offerings

Table 61. Ankang Health Element Recent Development

Table 62. Jiangsu Tiansheng Company Information

Table 63. Jiangsu Tiansheng Introduction and Business Overview

Table 64. Jiangsu Tiansheng Puerarin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 65. Jiangsu Tiansheng Puerarin Product Offerings

Table 66. Jiangsu Tiansheng Recent Development

Table 67. Xi'an Plamed Company Information

Table 68. Xi'an Plamed Introduction and Business Overview

Table 69. Xi'an Plamed Puerarin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 70. Xi'an Plamed Puerarin Product Offerings

Table 71. Xi'an Plamed Recent Development

Table 72. Xi'an Sobeo Company Information

Table 73. Xi'an Sobeo Introduction and Business Overview

Table 74. Xi'an Sobeo Puerarin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Xi'an Sobeo Puerarin Product Offerings

Table 76. Xi'an Sobeo Recent Development

Table 77. Ankang Health Element Company Information

Table 78. Ankang Health Element Introduction and Business Overview

Table 79. Ankang Health Element Puerarin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 80. Ankang Health Element Puerarin Product Offerings

Table 81. Ankang Health Element Recent Development

Table 82. Shanxi Zhongyi Herb Company Information

Table 83. Shanxi Zhongyi Herb Introduction and Business Overview

Table 84. Shanxi Zhongyi Herb Puerarin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 85. Shanxi Zhongyi Herb Puerarin Product Offerings

Table 86. Shanxi Zhongyi Herb Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Puerarin Downstream Customers

Table 90. Puerarin Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Puerarin Product Picture

Figure 2. Global Puerarin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Puerarin Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Puerarin Sales Volume (2020-2031) & (Tons)

Figure 5. Global Puerarin Sales Price (2020-2031) & (US$/Ton)

Figure 6. Puerarin Report Years Considered

Figure 7. Global Puerarin Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Puerarin Players Sales Volume Ranking (2024) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Puerarin Revenue in 2024

Figure 10. Puerarin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 98% Content Picture

Figure 12. Other Content Picture

Figure 13. Global Puerarin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Puerarin Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Puerarin Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)

Figure 16. Global Puerarin Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Puerarin Price by Type (2020-2031) & (US$/Ton)

Figure 18. Product Picture of Pharmaceutical

Figure 19. Product Picture of Research

Figure 20. Global Puerarin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Puerarin Sales Value Market Share by Application, 2024 & 2031

Figure 22. Global Puerarin Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)

Figure 23. Global Puerarin Sales Volume Market Share by Application, 2024 & 2031

Figure 24. Global Puerarin Price by Application (2020-2031) & (US$/Ton)

Figure 25. North America Puerarin Sales Value (2020-2031) & (US$ Million)

Figure 26. North America Puerarin Sales Value by Country (%), 2024 VS 2031

Figure 27. Europe Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 28. Europe Puerarin Sales Value by Country (%), 2024 VS 2031

Figure 29. Asia Pacific Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 30. Asia Pacific Puerarin Sales Value by Region (%), 2024 VS 2031

Figure 31. South America Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 32. South America Puerarin Sales Value by Country (%), 2024 VS 2031

Figure 33. Middle East & Africa Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 34. Middle East & Africa Puerarin Sales Value by Country (%), 2024 VS 2031

Figure 35. Key Countries/Regions Puerarin Sales Value (%), (2020-2031)

Figure 36. Key Countries/Regions Puerarin Sales Volume (%), (2020-2031)

Figure 37. United States Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 38. United States Puerarin Sales Value by Type (%), 2024 VS 2031

Figure 39. United States Puerarin Sales Value by Application (%), 2024 VS 2031

Figure 40. Europe Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 41. Europe Puerarin Sales Value by Type (%), 2024 VS 2031

Figure 42. Europe Puerarin Sales Value by Application (%), 2024 VS 2031

Figure 43. China Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 44. China Puerarin Sales Value by Type (%), 2024 VS 2031

Figure 45. China Puerarin Sales Value by Application (%), 2024 VS 2031

Figure 46. Japan Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 47. Japan Puerarin Sales Value by Type (%), 2024 VS 2031

Figure 48. Japan Puerarin Sales Value by Application (%), 2024 VS 2031

Figure 49. South Korea Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 50. South Korea Puerarin Sales Value by Type (%), 2024 VS 2031

Figure 51. South Korea Puerarin Sales Value by Application (%), 2024 VS 2031

Figure 52. Southeast Asia Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 53. Southeast Asia Puerarin Sales Value by Type (%), 2024 VS 2031

Figure 54. Southeast Asia Puerarin Sales Value by Application (%), 2024 VS 2031

Figure 55. India Puerarin Sales Value, (2020-2031) & (US$ Million)

Figure 56. India Puerarin Sales Value by Type (%), 2024 VS 2031

Figure 57. India Puerarin Sales Value by Application (%), 2024 VS 2031

Figure 58. Puerarin Industrial Chain

Figure 59. Puerarin Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Puerarin market? zhanKai

The top companies in the global Puerarin market are Ankang Health Element、Jiangsu Tiansheng、Xi'an Plamed.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Puerarin market size from 2025 to 2031? shouQi

What was the global market size of Puerarin in 2031? shouQi

What was the global market size of Puerarin in 2025? shouQi

Related Reports

Puerarin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Puerarin was estimated to be worth US$ 119 million in 2025 and is projected to reach US$ 186 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 129
USD 3950.00
(Single User License)
Global Puerarin Market Research Report 2026
The global Puerarin market was valued at US$ 119 million in 2025 and is anticipated to reach US$ 186 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 134
USD 2900.00
(Single User License)
Global Puerarin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Puerarin market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 176 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Global Puerarin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Puerarin market is projected to grow from US$ 112 million in 2024 to US$ 176 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 137
USD 4900.00
(Single User License)
Global Puerarin Market Research Report 2025
The global market for Puerarin was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 176 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-01-16
Pages: 90
USD 2900.00
(Single User License)
Global Puerarin Market Insights, Forecast to 2030
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published Date: 2024-04-12
Pages: 89
USD 4900.00
(Single User License)
Global Puerarin Market Research Report 2024
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published Date: 2024-01-17
Pages: 90
USD 2900.00
(Single User License)
Puerarin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published Date: 2024-01-10
Pages: 94
USD 3950.00
(Single User License)

Puerarin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Puerarin was estimated to be worth US$ 119 million in 2025 and is projected to reach US$ 186 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 129
USD 3950.00 (Single User License)
Global Puerarin Market Research Report 2026
The global Puerarin market was valued at US$ 119 million in 2025 and is anticipated to reach US$ 186 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-04-18
Pages: 134
USD 2900.00 (Single User License)
Global Puerarin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Puerarin market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 176 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)
Global Puerarin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Puerarin market is projected to grow from US$ 112 million in 2024 to US$ 176 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 137
USD 4900.00 (Single User License)
Global Puerarin Market Research Report 2025
The global market for Puerarin was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 176 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-01-16
Pages: 90
USD 2900.00 (Single User License)
Global Puerarin Market Insights, Forecast to 2030
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published: 2024-04-12
Pages: 89
USD 4900.00 (Single User License)
Global Puerarin Market Research Report 2024
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published: 2024-01-17
Pages: 90
USD 2900.00 (Single User License)
Puerarin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published: 2024-01-10
Pages: 94
USD 3950.00 (Single User License)